ReviewTherapeutic advances in gastroenterology2025
Linked color imaging for the detection and treatment of serrated colon neoplasia: current status and future perspective.
Review in Therapeutic advances in gastroenterology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Diagnostic value of linked color imaging for detecting gastritis subtypes and precancerous lesions.American journal of translational research · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Colorectal cancer (CRC) remains the second leading cause of global cancer-related mortality, with serrated colon neoplasia (SCN) accounting for 20%-30% of cases. SCN exhibits distinct clinicopathological and molecular features, whose superficial and pale appearance poses challenges for endoscopic detection. Linked Color Imaging (LCI) significantly improves lesion detection by enhancing color contrast through narrowband preprocessing and post-processing augmentation, demonstrating superior performance in large-lumen examinations. This review synthesizes current knowledge on the clinicopathological and molecular profiles of SCN, elaborates on the technical advantages of LCI over conventional imaging modalities, and highlights its diagnostic utility in SCN screening. Furthermore, we explore the innovative integration of LCI with artificial intelligence for real-time lesion recognition and with biomedical nanomaterials for targeted therapy, proposing a promising "detection-treatment" paradigm that may transform early CRC management.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.